JAK Inhibitors Show Promise for Alopecia, Eczema, Vitiligo JAK Inhibitors Show Promise for Alopecia, Eczema, Vitiligo

A researcher at the forefront shares promising results from small studies. Clinical trials are in progress and he predicts FDA approval for a JAK inhibitor for alopecia and eczema within 3 years.Medscape Medical News

Source: Medscape Medical News Headlines - March 7, 2017 Category: Consumer Health News Tags: Dermatology News Source Type: news